Medical device maker Boston Scientific shares rise after rating boost

Boston Scientific Corp.’s stock jumps as much as 6 percent after RBC Capital Markets boosts its rating of the medical device maker’s stock.

Boston Scientific (NYSE:BSX) is getting a big boost this morning, climbing as much as 6 percent in early trading after RBC Capital Markets reportedly raised its rating for the medical device maker’s stock.

BSX shares touched $7.62 apiece early today, before backing down to its current range of about $7.50 per share. The stock last traded this high just one week ago, before sliding nearly 7 percent between Tuesday and Thursday’s close.

Advertisement
MassDevice Staff

MassDevice Staff

The Massachusetts Medical Devices Journal is the online journal of the medical devices industry in the Commonwealth and New England, providing day-to-day coverage of the devices that save lives, the people behind them, and the burgeoning trends and developments within the industry.

about | more

Comments RSS Post a comment

No comments yet.

Post a Comment

Submit Comment

Be a Thought Leader: Join MedCitizens

Anyone can blog on MedCity News when they become a "MedCitizen." MedCitizens publish their own thoughts about current medical news and the latest issues in healthcare to the entire MedCity News audience.

Click to login or learn more

MedCity Jobs Board


MedCity Whitepapers

Real Time Web Analytics